EPISODE · Mar 30, 2026
Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI
from Vitals & Signals
The FDA is quietly rewriting the fundamental contract of clinical AI regulation — moving from a pre-market permission slip to a post-market surveillance regime — and every founder, investor, and clinician in this industry needs to understand what that means before the framework lands.
Embed this episode
NOW PLAYING
Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI
0:00
0:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
When was this Vitals & Signals episode published?
This episode was published on March 30, 2026.
Can I download this Vitals & Signals episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!